Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biomedical Innovation Departament, |
RCV001352756 | SCV001547290 | pathogenic | Epidermolysis bullosa dystrophica | 2017-11-11 | criteria provided, single submitter | research | |
Invitae | RCV001529155 | SCV003525548 | pathogenic | not provided | 2023-05-20 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg682*) in the COL7A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COL7A1 are known to be pathogenic (PMID: 16971478). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1047976). This premature translational stop signal has been observed in individual(s) with autosomal recessive epidermolysis bullosa dystrophica (PMID: 10504458, 29473190). This variant is present in population databases (no rsID available, gnomAD 0.3%). |
Diagnostic Laboratory, |
RCV001529155 | SCV001742155 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001529155 | SCV001956610 | pathogenic | not provided | no assertion criteria provided | clinical testing |